C
Chantal B.E.M. Reusken
Researcher at Erasmus University Rotterdam
Publications - 52
Citations - 13819
Chantal B.E.M. Reusken is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 27 publications receiving 10420 citations. Previous affiliations of Chantal B.E.M. Reusken include Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
Alvin X. Han,Eva Kozanli,Jelle Koopsen,Harry Vennema,Karim Hajji,Annelies Kroneman,Ivo Van Walle,Don Klinkenberg,Jacco Wallinga,Colin A. Russell,Dirk Eggink,Chantal B.E.M. Reusken +11 more
TL;DR: The findings show that flight restrictions had limited effectiveness in deterring VOC introductions due to the strength of regional land travel importation risks, and highlight that robust surveillance in regions of early spread is important for providing timely information for variant detection and outbreak control.
Posted ContentDOI
Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
Alvin X. Han,Eva Kozanli,Jelle Koopsen,Harry Vennema,Karim Hajji,Annelies Kroneman,Ivo Van Walle,Don Klinkenberg,Jacco Wallinga,Colin A. Russell,Dirk Eggink,Chantal B.E.M. Reusken +11 more
TL;DR: Findings show that flight restrictions had limited effectiveness in deterring VOC introductions due to the strength of regional land travel importation risks, and highlight that robust surveillance in regions of early spread is important for providing timely information for variant detection and outbreak control.
Journal ArticleDOI
Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories
Ramona Mögling,F. Fischer,Kamelia R. Stanoeva,Angeliki Melidou,A. C. Almeida Campos,Christian Drosten,Barbara Biere,Adam Meijer,Annette Kraus,Chantal B.E.M. Reusken,Jan Felix Drexler +10 more
TL;DR: In this article , an external quality assessment (EQA) on the molecular detection and variant typing of SARS-CoV-2 that included 59 European laboratories in 34 countries was conducted.
Posted ContentDOI
Potential environmental transmission routes of SARS-CoV-2 inside a large meat processing plant experiencing COVID-19 clusters
Myrna M.T. de Rooij,Reina S. Sikkema,Martijn Bouwknegt,Yvette de Geus,Kamelia R. Stanoeva,Sigrid Nieuwenweg,Sandra van Dam,Ceder Raben,Wietske Dohmen,Dick Heederik,Chantal B.E.M. Reusken,Adam Meijer,Marion Koopmans,Eelco Franz,Lidwien A.M. Smit +14 more
TL;DR: In this paper, the authors performed SARS-CoV-2 screening of workers operating in cooled production rooms and intensive environmental sampling during a two-week study period in June 2020.
Journal ArticleDOI
Differential vaccine-induced kinetics of humoral and cellular immune responses in SARS-CoV-2 naive and convalescent health care workers
Wouter L. Smit,Steven F. T. Thijsen,Robert van der Kieft,Sophie van Tol,Johan Reimerink,Chantal B.E.M. Reusken,Lidewij Rumke,Aik Bossink,Gijs J M Limonard,M M Heron +9 more
TL;DR: It was found that convalescent individuals mounted higher spike-specific INF-y-secreting T cell responses and B- cell-mediated IgG responses, after receiving the Janssen vaccine or the first dose of the Pfizer vaccine, which supports the implemented single-dose mRNA booster strategy employed in the Netherlands.